Chargement en cours...
Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure
AIM: Portal hypertension is a common complication of liver cirrhosis and significantly increases mortality and morbidity. Previous reports have suggested that the compound thalidomide attenuates portal hypertension (PHT). However, the mechanism for this action is not fully elucidated. One hypothesis...
Enregistré dans:
| Publié dans: | World J Gastroenterol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Inc
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4394073/ https://ncbi.nlm.nih.gov/pubmed/25892862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i14.4126 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|